How does Cognizant return value to shareholders?

2021 revenue growth guidance was at 11.1%, or 9.8% in constant currency Currently Cognizant Technology Solutions Corp. has a market cap of $38.24 Billion. It ... The Element i+™ immunodiagnostic analyzer supports diagnostic needs with total T4, cortisol, progesterone, cTSH, cCRP, and the Nu.Q® cancer test. Apr 7, 2025 ... Ctsh cathepsin H [ Mus musculus (house mouse) ] · Summary · Genomic context · Genomic regions, transcripts, and products · Expression · Bibliography. their cleavage products; prepared edible fats; animal or vcEetable viaxes. CTSH +VA 4Oo/o. Chapter 16. Preparations of meat, of fish or of crustaceans, ... Latest Quarter | Q1 2025 · Press Release · Presentation · Infographic · Webcast · Transcript · Form 10-Q(opens in new window) · All Quarters Investor Toolkit ... Objective-To determine effect of time of sample collection on serum thyrotropin (canine thyroid-stimu- lating hormone [cTSH]) concentrations in euthyroid. Drive faster, predictive and proactive decision-making. ... Boost operational efficiency, optimize costs and speed product development. ... Reimagine the customer ... Jun 15, 2016 ... ... cTSH), occur in about 25 percent of hypothyroid dogs. False-positive results (elevated cTSH), occur in about 10 percent of dogs with NTI and ... As of 2025-05-03, the Intrinsic Value of Cognizant Technology Solutions Corp (CTSH) is 81.08 USD. This Cognizant valuation is based on the model Discounted Cash ... Description. Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the ...